Evidence map›Paper›PMID 36153767›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2022

Reactions of cisplatin and oxaliplatin with penicillin G: implications for drug inactivation and biological activity.

Fang-Xin Wang, Ivan Prokes, Lijiang Song, Huayun Shi, Peter J Sadler

Open access · hybridAbstract read
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Fang-Xin WangDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.
Ivan ProkesDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.
Lijiang SongDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.
Huayun ShiDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, UK.
Peter J SadlerDepartment of Chemistry, University of Warwick, Coventry, CV4 7AL, UK. p.j.sadler@warwick.ac.uk.ORCID 0000-0001-9160-1941
University of Warwick · GBSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determination of the toxicity of compounds toward cancer cells is a frequent procedure in drug discovery. For metal complexes, which are often reactive prodrugs, care has to be taken to consider reactions with components of the cell culture medium that might change the speciation of the metal complex before it is taken up by the cells. Here, we consider possible reactions between the clinical platinum drugs cisplatin and oxaliplatin with penicillin G, an antibiotic added routinely to cell culture media to prevent bacterial contamination. Platinum has a high affinity for ligands with sulfur donors. Penicillin G is an unstable thioether that degrades in a range of pathways. Nuclear magnetic resonance (NMR) and UV-Vis absorption spectroscopic studies show that reactions with cisplatin can occur within minutes to hours at 310 K, but more slowly with oxaliplatin. The identities of the Pt- adducts were investigated by mass spectrometry. The marked effect on cytotoxicity of co-incubation of cisplatin with penicillin G was demonstrated for the HeLa human cervical cancer cell line. These studies highlight the possibility that reactions with penicillin G might influence the cytotoxic activity of metal complexes determined in culture media.

Indexed as

Antineoplastic AgentsCoordination ComplexesCisplatinHumansOrganoplatinum CompoundsOxaliplatinPenicillin GPlatinumAntineoplastic AgentsCisplatinCoordination ComplexesOrganoplatinum CompoundsOxaliplatinPenicillin GPlatinumChemotherapyCisplatinDegradationOxaliplatinPenicillin G

Identifiers

PMID36153767
PMCPMC9653338
OpenAlexW4297058757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.